Donald A. Denkhaus, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), bought 50,000 shares at $2.03 ($102K) on 2016-01-07, disclosed to the SEC on 2016-01-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.03 | 25,000 | $51K | 50.0% |
| 2 | $2.03 | 25,000 | $51K | 50.0% |
| Total | $2.03 avg | 50,000 | $102K | 100% |
| Filing → |
| CPRX | BUY | 2018-12-28 | $48K | — | Filing → |
| CPRX | BUY | 2018-12-17 | $149K | — | Filing → |
| CPRX | BUY | 2018-06-11 | $68K | — | Filing → |